Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience

PURPOSE: To characterize our experience and the disease control and toxicity of proton therapy (PT) for patients with head and neck cancer (HNC). PATIENTS AND METHODS: Clinical outcomes for patients with HNC treated with PT at our institution were prospectively collected in 2 institutional review bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunn, G. Brandon, Garden, Adam S., Ye, Rong, Ausat, Noveen, Dahlstrom, Kristina R., Morrison, William H., Fuller, C. David, Phan, Jack, Reddy, Jay P., Shah, Shalin J., Mayo, Lauren L., Chun, Stephen G., Chronowski, Gregory M., Moreno, Amy C., Myers, Jeffery N., Hanna, Ehab Y., Esmaeli, Bita, Gillison, Maura L., Ferrarotto, Renata, Hutcheson, Katherine A., Chambers, Mark S., Ginsberg, Lawrence E., El-Naggar, Adel K., Rosenthal, David I., Zhu, Xiaorong Ronald, Frank, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2021
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270083/
https://www.ncbi.nlm.nih.gov/pubmed/34285940
http://dx.doi.org/10.14338/IJPT-20-00065.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270083/
https://www.ncbi.nlm.nih.gov/pubmed/34285940
http://dx.doi.org/10.14338/IJPT-20-00065.1

Ejemplares similares